Clinical Trial Update: Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical study evaluating sequential administration of Interleukin-12 followed by Interferon alfa in adults with advanced cancer; the trial status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Syndromes
• Myeloproliferative Disorders
• Precancerous Condition
• Unspecified Adult Solid Tumor

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Interleukin-12 (interleukin-12)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 1 | Status: COMPLETED